Aperio Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$3.86M Buy
125,983
+37,454
+42% +$1.14M 0.01% 944
2020
Q3
$2.47M Sell
88,529
-9,007
-9% -$228K 0.01% 1022
2020
Q2
$2.09M Sell
97,536
-15,764
-14% -$348K 0.01% 1091
2020
Q1
$2.54M Buy
113,300
+65,538
+137% +$1.8M 0.01% 921
2019
Q4
$1.41M Buy
47,762
+36,040
+307% +$979K 0.01% 1262
2019
Q3
$312K Buy
11,722
+9,052
+339% +$272K ﹤0.01% 1999
2019
Q2
$90K Buy
+2,670
New +$86.7K ﹤0.01% 2410

Other funds holding ELAN

Aperio Group's ELAN Position: Q4 2020 in Review

Aperio Group increased its Elanco Animal Health (ELAN) stake by 42% in Q4 2020, buying an estimated $1.14M and bringing the position to 125,983 shares worth $3.86M. The position accounts for 0.01% of the portfolio, ranked #944.

Aperio Group first reported a position in ELAN in Q2 2019 and has held it in 7 quarters since. 441 funds tracked by Wall St. Rank hold ELAN as of Q4 2020.

  • Aperio Group held 125,983 shares of Elanco Animal Health worth $3.86M as of Q4 2020.
  • Aperio Group bought 37,454 Elanco Animal Health shares in Q4 2020, an estimated $1.14M.
  • Elanco Animal Health made up 0.01% of Aperio Group's portfolio in Q4 2020, its #944 holding.
  • Aperio Group first reported a position in Elanco Animal Health in Q2 2019 and has held it in 7 quarters since.
  • 441 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.